Results 271 to 280 of about 1,080,358 (387)
Implementation of guidelines for intravenous iron therapy in heart failure patients
Abstract Aims We aim to evaluate the implementation of the 2021 ESC Guidelines regarding screening and treatment of iron deficiency in patients with heart failure (HF) at Karolinska University Hospital. Methods and results Patients with left ventricular ejection fraction (LVEF) < 50% and New York Heart Association (NYHA) class II–IV who visited ...
Milou Gamage+5 more
wiley +1 more source
Canagliflozin protects cardiovascular function in type 2 diabetic coronary artery disease by regulating natriuretic peptide B. [PDF]
Zhang J+5 more
europepmc +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 727-729, April 2025.
Wojciech Kosmala+1 more
wiley +1 more source
Abstract Aims Most proteomic analyses in patients with heart failure (HF) focus on the stable ambulatory setting; pathways that drive acute decompensated heart failure (ADHF) are largely uncharacterized. We aimed to examine the associations of cardiometabolic proteins with HF rehospitalization, mortality and diuretic response in patients with ADHF ...
Kenneth T. Hubbell+8 more
wiley +1 more source
The role of atrial natriuretic peptide (ANP) in chronic liver disease. [PDF]
Almeida+82 more
core +1 more source
Home‐operated ultrasound exam for detection of worsening heart failure (HOUSE‐HF)
Abstract Aims Acute decompensated heart failure (ADHF) is associated with a high degree of morbidity and mortality. Dynamic lung ultrasound artefact called B‐lines can be obtained at the bedside and directly correlate with pulmonary vascular congestion. Obtaining patient‐performed lung ultrasound images in the outpatient setting is novel.
Stuart B. Prenner+4 more
wiley +1 more source
Rab3gap1 palmitoylation cycling modulates cardiomyocyte exocytosis and atrial natriuretic peptide release. [PDF]
Essandoh K+3 more
europepmc +1 more source
Abstract Chronic kidney disease (CKD) and chronic heart failure (HF) frequently coexist and, when comorbid, are associated with poorer outcomes. These two diseases have common risk factors, such as diabetes, obesity and hypertension, and common pathophysiological connected mechanisms, including inflammation, endothelial dysfunction, neurohormonal ...
Johann Bauersachs+2 more
wiley +1 more source